[Form 4] HUNTINGTON INGALLS INDUSTRIES, INC. Insider Trading Activity
Rhea-AI Filing Summary
Huntington Ingalls Industries director Stephanie L. O'Sullivan received dividend-equivalent stock units under the company's 2012 and 2022 Long-Term Incentive Stock Plans. On 09/12/2025 the reporting person was credited 17.534 SUA units, valued for reporting at $0 per unit, increasing her beneficial ownership to 3,585.429 shares. Each SUA represents a right to one common share and dividend equivalents are calculated by dividing the aggregate cash dividend on the director's SUAs by the closing stock price on the dividend payment date. SUAs generally convert to shares within about 30 days after a non-employee director leaves the board.
Positive
- Dividend-equivalent credits were applied under the LTISPs, increasing the director's beneficial ownership to 3,585.429 shares.
- Disclosure is timely and complete for this plan-driven transaction, with Form 4 filed and signed by an attorney-in-fact.
Negative
- None.
Insights
TL;DR: Routine director dividend-equivalent credit; immaterial to company financials but increases insider share count slightly.
This Form 4 reports a non-cash, plan-driven credit of 17.534 director stock units that arise from dividend equivalents under the LTISPs. The transaction is administrative and reflects compensation mechanics rather than open-market trading; it does not show cash proceeds or exercised options. The post-transaction beneficial ownership reported is 3,585.429 shares, which is useful for tracking insider alignment but is not large enough, on its face, to be material to HII's capitalization.
TL;DR: Standard director compensation mechanics executed; reflects governance practice of using SUAs to mirror economic dividends.
The filing documents routine application of the company’s LTISPs where dividend equivalents accrue to director SUAs and are converted based on quarterly dividend amounts and closing price. This preserves alignment of non-employee directors with shareholders without immediate share issuance while maintaining disclosure transparency. No departures, sales, or option exercises are reported, and the form includes an attorney-in-fact signature indicating standard filing procedure.